MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients - sprookjes - yvandenbroek - TriplyDB

MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients

MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients

http://www.wikidata.org/entity/Q26865275

about

Export of microRNAs: A Bridge between Breast Carcinoma and Their Neighboring Cells RAS-MAPK pathway epigenetic activation in cancer: miRNAs in action MicroRNAs: Clinical Relevance in Colorectal Cancer MicroRNA-7: a promising new target in cancer therapy Therapeutic Resistance in Acute Myeloid Leukemia: The Role of Non-Coding RNAs Current Status of Long Non-Coding RNAs in Human Breast Cancer Function and Clinical Implications of Long Non-Coding RNAs in Melanoma.MicroRNA-135a-3p as a promising biomarker and nucleic acid therapeutic agent for ovarian cancer.A microRNA biomarker of hepatocellular carcinoma recurrence following liver transplantation accounting for within-patient heterogeneity.A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas Prognostic significance of tissue miR-345 downregulation in non-small cell lung cancer miR-186 inhibits cell proliferation of prostate cancer by targeting GOLPH3 Relevance of MicroRNA200 Family and MicroRNA205 for Epithelial to Mesenchymal Transition and Clinical Outcome in Biliary Tract Cancer Patients.Suppressing role of miR-520a-3p in breast cancer through CCND1 and CD44.Clinical value of integrated-signature miRNAs in esophageal cancer.Targeted Agents in Preclinical and Early Clinical Development for the Treatment of Cancer Bone Metastases.miR-146a-5p mediates epithelial-mesenchymal transition of oesophageal squamous cell carcinoma via targeting Notch2.MiR-24-3p enhances cell growth in hepatocellular carcinoma by targeting metallothionein 1M.miR-373 Inhibits Glioma Cell U251 Migration and Invasion by Down-Regulating CD44 and TGFBR2.Let-7d miRNA Shows Both Antioncogenic and Oncogenic Functions in Osteosarcoma-Derived 3AB-OS Cancer Stem Cells.miR-539 induces cell cycle arrest in nasopharyngeal carcinoma by targeting cyclin-dependent kinase 4.Liposarcoma: molecular targets and therapeutic implications.Extracellular miRNAs as biomarkers in cancer.Noncoding RNAs: New Players in Cancers.Noncoding RNAs and immune checkpoints-clinical implications as cancer therapeutics.Current Insights into Long Non-Coding RNAs (LncRNAs) in Prostate Cancer What Is New in the miRNA World Regarding Osteosarcoma and Chondrosarcoma?MicroRNAs as a tool to aid stratification of colorectal cancer patients and to guide therapy.Genome-Wide miRNA Analysis Identifies miR-188-3p as a Novel Prognostic Marker and Molecular Factor Involved in Colorectal Carcinogenesis.MicroRNA target for MACC1 and CYR61 to inhibit tumor growth in mice with colorectal cancer.MicroRNA fingerprints in juvenile myelomonocytic leukemia (JMML) identified miR-150-5p as a tumor suppressor and potential target for treatment Comprehensive Analysis of miRNome Alterations in Response to Sorafenib Treatment in Colorectal Cancer Cells.Targeting MicroRNAs in Prostate Cancer Radiotherapy.MicroRNAs in Different Histologies of Soft Tissue Sarcoma: A Comprehensive Review.Polychlorinated biphenyl exposure alters the expression profile of microRNAs associated with vascular diseases Fibroblast miR-210 overexpression is independently associated with clinical failure in Prostate Cancer - a multicenter (in situ hybridization) study.Differential Expression of MicroRNAs in Leprosy Skin Lesions.CDK3, target of miR-4469, suppresses breast cancer metastasis via inhibiting Wnt/β-catenin pathway.Harnessing the heart's resistance to malignant tumors: cardiac-derived extracellular vesicles decrease fibrosarcoma growth and leukemia-related mortality in rodents.The role of miRNA and lncRNA in gastric cancer.

P2860

Q26744487-6ED60E4E-1436-4536-A6B7-B6647142CCD0 Q26773479-8D9CD2D3-0925-448D-8952-93F83BA55FE4 Q26776039-B23A4656-C929-4CD3-98B1-6D57795325D5 Q26777905-02A8EC6C-468B-4F22-B1D0-92862F03E5ED Q28071427-BD009992-CB07-4D27-B8DD-9BA7783DD9F5 Q28079880-934DDF6E-275B-4208-BD2B-D3A2D8F48F0C Q30313298-97D48019-20E3-4C26-94E0-7F0402E76486 Q33738954-BD73A6E4-1F66-4BB7-808E-5AD83538B2C5 Q35984012-368E406E-93F2-4062-86FD-63A6C26B448D Q36091092-03B8FC33-7989-4759-914E-05D827DA50BB Q36492927-B3B07E21-BA94-447B-B24C-CB78670E1E15 Q37215525-291E61AE-C2B6-4676-8EB2-3E1C2431A857 Q37534719-41BEF05A-098A-4745-AF1A-B43A03991980 Q37596880-49BD9EA5-B512-455E-B2EC-F55B0D857DDD Q38679534-665B64AC-E181-4473-8369-3C72A9339BE4 Q38700342-F25B739D-6ACF-4166-AB96-CA2ADD0C5BEA Q38731888-CAAF7FA9-ACBB-4E16-910C-1D950F5CFE86 Q38744683-B6F88C96-449F-45B6-9033-3FB53D30D00B Q38795514-E3E4AA37-F4F4-449F-BD48-DBAD7E093455 Q38810898-DA5C5273-C1C0-4D0C-BFC9-672E0FD48973 Q38820169-1B8CE0E1-76C8-43A4-9DBE-228E49D7CA3B Q38833050-3568EDE6-EDA9-4FC1-A1FB-36D460400EEF Q38867417-45D1BA1F-D2C3-4722-B7D1-B42B126E6376 Q38885461-70F73112-F4BF-4F7D-A489-BECAC8E5DC6B Q39108144-47FC8B31-2757-420A-B7C6-6D06AB3D0B7A Q39152842-2F777E28-1422-48C0-ABF4-68F89ACE3D48 Q39168132-E51C0BC5-6993-4825-AE16-4DA44FB5070E Q39390383-5B875061-A3B8-43AD-AC84-7AA6C6B2988C Q39416069-597C0AF5-6256-4877-B981-0A74FF5D54DF Q39523091-AB7A8906-3B3A-43B8-97E9-F66E89F9215D Q39570483-94F30ADC-8CDF-46C2-AFCA-5A550AF149E5 Q39934280-781E6FFC-5245-42EB-9BA2-C8DF30945769 Q41239908-50035CDF-69AB-4A5A-A728-0B782D40985F Q41660637-38BD5527-1C42-4A1C-B235-69D59567DA9C Q41880423-AA495FDB-9DA1-4ECA-96E8-53C058C087A2 Q41991354-9AA4D49C-90B2-4F0B-96C0-3F84F4FB6FD9 Q41991878-71A40DF8-4BBD-4A1A-8235-10D4EC6AF680 Q43951442-E89DC9B6-74A2-4656-981D-76775C760183 Q47104850-A8B23C38-9C16-49C7-A2BD-56E412DA653A Q47117573-13615E39-464E-42CC-A1FD-F6A02B06E3A0

P2860

MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients

http://www.wikidata.org/entity/Q26865275

description

2015 nî lūn-bûn

@nan

2015 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

MicroRNAs in cancer: from deve ...... inical application in patients

@ast

MicroRNAs in cancer: from deve ...... inical application in patients

@en

MicroRNAs in cancer: from deve ...... inical application in patients

@nl

type

label

MicroRNAs in cancer: from deve ...... inical application in patients

@ast

MicroRNAs in cancer: from deve ...... inical application in patients

@en

MicroRNAs in cancer: from deve ...... inical application in patients

@nl

prefLabel

MicroRNAs in cancer: from deve ...... inical application in patients

@ast

MicroRNAs in cancer: from deve ...... inical application in patients

@en

MicroRNAs in cancer: from deve ...... inical application in patients

@nl

P1433

Q26865275-2553C4A0-A6FC-4BC4-9614-9A99F813A707

P1476

Q26865275-CCCF1EC2-4213-4B54-B625-8A3FA8DAD785

P2093

Q26865275-A8C1D0F0-E53B-49FA-834C-841E10238B07

P275

Q26865275-7BC03E96-86BE-4143-AE18-C9F24E9F9676

P2860

Q26865275-03686F3A-8962-4034-A955-08CFEB05AA88

Q26865275-1216316F-02A4-4757-B818-12CDE34F60C0

Q26865275-39A052EE-FCB4-45B9-9275-F43BCC09A03B

Q26865275-41665BA6-AC94-46AC-BD36-4162514E2B21

Q26865275-444ED52C-7DA6-4F4D-93DB-878F6E6D8621

Q26865275-44E347DC-80FD-46F5-B1C4-8D5E9931EE09

Q26865275-48A22E50-0A9A-4484-8779-40A26B9F6B65

Q26865275-510E6997-021B-48F9-8400-98E8A8ECFD01

Q26865275-6862771C-9675-4E38-97DF-5D33CC65AF43

Q26865275-72F8D748-A399-41FD-8FD7-55946D81D5D8

P2888

Q26865275-4C3DAB54-F789-462B-9224-78FA8B2F67A1

P304

Q26865275-0F7BF513-3EAC-44E4-A1A9-20A5B68D46F8

P31

Q26865275-021752F6-7EA5-4645-8FD0-A780536A210A

Q26865275-F7DEF31E-3B81-4752-8AC9-01C099ABEB1D

P3181

Q26865275-61D1600C-641B-4BDE-B9C3-D8937C66D0AC

P356

Q26865275-D16E9DA0-1433-4B5F-A718-86D2603F2AF4

P407

Q26865275-2FD7E309-9942-45B0-861B-CDB6EA00D372

P433

Q26865275-985743CA-FC3A-42AD-8DAD-2F43744EACAF

P478

Q26865275-A7D0FFAA-10C0-4555-B72A-D7F83D5370EB

P50

Q26865275-D26680C1-D28B-4A6C-955F-B63A8A4D9170

P5008

Q26865275-E94012D4-F4D3-4A21-AB98-42B61C416F0E

P577

Q26865275-E97A66DE-ABD2-468A-B151-6FE2D0445974

P5875

Q26865275-C9122E7A-06C7-4AF5-932F-A09B6A6D53C1

P6179

Q26865275-CCF70B5D-A713-407A-A50C-CCE165EEB385

P698

Q26865275-92CCC9DC-CE23-4011-BC1D-C280DDF95824

P921

Q26865275-6BBA7B93-26F5-461D-9312-BA59DEB4B901

Q26865275-BB5BA38F-B5C7-4550-B8BD-F73BD048406B

Q26865275-C50DCBFF-FA89-4267-9FD7-8F2051AA5603

P932

Q26865275-07865667-AD36-4D68-8AFA-54C475BC12C6

P3181

P356

P1433

British Journal of Cancer

P1476

MicroRNAs in cancer: from deve ...... inical application in patients

@en

P2093

M Pichler

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia

Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans

The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14

Identification of novel genes coding for small expressed RNAs

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

MicroRNA signatures in human cancers

Reduced lung-cancer mortality with low-dose computed tomographic screening

A let-7 microRNA-binding site polymorphism in 3'-untranslated region of KRAS gene predicts response in wild-type KRAS patients with metastatic colorectal cancer treated with cetuximab monotherapy

Regulation of heparin-binding EGF-like growth factor by miR-212 and acquired cetuximab-resistance in head and neck squamous cell carcinoma

Sputum microRNA biomarkers for identifying lung cancer in indeterminate solitary pulmonary nodules.

P2888

P304

569-73

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

657323

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/BJC.2015.253

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

113

http://www.w3.org/2001/XMLSchema#string

P50

George A. Calin

P5008

P577

2015-08-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

279989829

http://www.w3.org/2001/XMLSchema#string

P6179

1040791125

http://www.w3.org/2001/XMLSchema#string

P698

26158421

http://www.w3.org/2001/XMLSchema#string

P921

P932

4647691

http://www.w3.org/2001/XMLSchema#string